[Plasmapheresis in amiodarone-induced hyperthyroidism].
Camarero
V
V
Llata
L
L
Ruiz
E
E
Torres
G
G
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D002637:Chest Pain / Q000209:etiology; D002761:Cholangitis / Q000139:chemically induced; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D007037:Hypothyroidism / Q000139:chemically induced; D008297:Male; D008713:Methimazole / Q000009:adverse effects / Q000627:therapeutic use; D010956:Plasmapheresis
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D013956:Antithyroid Agents; D005938:Glucocorticoids; D008713:Methimazole; D000638:Amiodarone